CPTA — Impact Through Optimization of Clinical Trial Design CPTA — Impact Through Optimization of Clinical Trial Design Inherited ataxias are a diverse collection of genetic disorders that
Drug Repurposing Provides Big Impact for Patients Drug Repurposing Provides Big Impact for Patients C-Path’s CDRC is positioned to inform future clinical trials for diseases
Duchenne Advocates Russell, Werth Use Platform to Amplify Patient Impact Duchenne Advocates Russell, Werth Use Platform to Amplify Patient Impact By Alexander Diegel Duchenne Regulatory Science Consortiu
How RDCA-DAP Delivers Impact and Support for Rare Disease Treatment Innovation How RDCA-DAP Delivers Impact and Support for Rare Disease Treatment Innovation With over 350 million people in the world living wi
Impact For Patients: International Neonatal Consortium Impact For Patients: International Neonatal Consortium INC’s work has created a paradigm shift in clinical drug development for
Impact For Patients: Critical Path for Parkinson’s Consortium Impact For Patients: Critical Path for Parkinson’s Consortium CPP is leading the path to the use of remote monitoring technologi
Impact For Patients: Patient-Reported Outcome Consortium Impact For Patients: Patient-Reported Outcome Consortium Patient-Reported Outcome (PRO) Consortium helps to provide drug developer
Impact For Patients: TTC’s Work to Qualify a Reasonably Likely Surrogate Endpoint Impact For Patients: Transplant Therapeutics Consortium TTC’s work to qualify a reasonably likely surrogate endpoint will speed
Impact For Patients: TTC’s iBox Scoring System Impact For Patients: Transplant Therapeutics Consortium These stories highlight the value and impact that C-Path’s Transplant Th
Impact on Industry and Patients: Polycystic Kidney Disease Outcomes Consortium Impact on Industry and Patients: Polycystic Kidney Disease Outcomes Consortium C-Path as Convener, Curator, Innovator and Accelera
